Neurocrine Biosciences (NBIX) drops 2.8%, to $8.40, after announcing a 9.5M share stock offering...

|About: Neurocrine Biosciences, Inc. (NBIX)|By:, SA News Editor

Neurocrine Biosciences (NBIX) drops 2.8%, to $8.40, after announcing a 9.5M share stock offering at a price of $8.10. The drug developer expects to use the proceeds to fund its R&D efforts, and for "general corporate purposes."